Table 2.
Outcome (progression-free survival) - Cox univariate and multivariable models
| Univariate models | HR | Std. error | P |
|---|---|---|---|
| β2M | |||
| β2M decreased/negative | 9.2 | 1.47 | 0.02 |
|
| |||
| MHC class I | |||
| MHC class I decreased/negative | 9.7 | 1.47 | 0.02 |
|
| |||
| MHC class II | |||
| MHC class II decreased/negative | 1.2 | 0.52 | 0.66 |
|
| |||
| 9p24.1 genetic status | |||
| 9p24.1 amplification | 3.3 | 0.47 | 0.01 |
|
| |||
| Clinical factors | |||
| Advanced stage | 3.1 | 0.46 | 0.01 |
|
| |||
| Multivariable models | HR | Std. error | P |
|
| |||
| MHC class I decreased/negative, 9p24.1 amplification | |||
| MHC class I decreased/negative | 7.3 | 1.48 | 0.05 |
| 9p24.1 amplification | 2.7 | 0.47 | 0.03 |
|
| |||
| MHC class I decreased/negative, advanced stage | |||
| MHC class I decreased/negative | 8.9 | 1.47 | 0.03 |
| Advanced stage | 2.9 | 0.47 | 0.02 |
|
| |||
| MHC class I decreased/negative, advanced stage, 9p24.1 amplification | |||
| MHC class I decreased/negative | 7.4 | 1.48 | 0.05 |
| Advanced stage | 2.5 | 0.47 | 0.04 |
| 9p24.1 amplification | 2.3 | 0.48 | 0.07 |